₹ 0.8 Cr
Volume Transacted
(Nov 8, 2024)
14.5 K
Stocks Traded
(Nov 8, 2024)
Last Updated on: Nov 08, 2024
Granules India Ltd
NSE: GRANULES
EPS
₹ 20.1
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Granules India Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 13,853 Cr
EPS
₹ 20.1
P/E Ratio (TTM) *
28.4
P/B Ratio (TTM) *
4.0
Day’s High *
577.05
Day’s Low
₹ 562.2
DTE *
0.3
ROE *
14.2
52 Week High
₹ 724.55
52 Week Low
₹ 353.05
ROCE *
16.9
* All values are consolidated
Last Updated time: 08 Nov 10:34 AM
* All values are consolidated
Last Updated time: 08 Nov 10:34 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 571.6 | 576.4 | 591.25 | 566 |
06 Nov 2024 | 576.3 | 553 | 586.6 | 547.05 |
05 Nov 2024 | 550.65 | 549.95 | 554 | 539 |
04 Nov 2024 | 549.65 | 571.9 | 571.9 | 547.9 |
01 Nov 2024 | 570.15 | 570.1 | 574.5 | 568.7 |
31 Oct 2024 | 569.6 | 551 | 572.55 | 551 |
30 Oct 2024 | 554.5 | 562.65 | 564.45 | 550.5 |
29 Oct 2024 | 554.3 | 556.25 | 565 | 538.2 |
28 Oct 2024 | 553 | 541 | 555.7 | 535.4 |
25 Oct 2024 | 539.45 | 560 | 560 | 531.25 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 571.6 |
06 Nov 2024 | 576.3 |
05 Nov 2024 | 550.65 |
04 Nov 2024 | 549.65 |
01 Nov 2024 | 570.15 |
31 Oct 2024 | 569.6 |
30 Oct 2024 | 554.5 |
29 Oct 2024 | 554.3 |
28 Oct 2024 | 553 |
25 Oct 2024 | 539.45 |
Strength
4
S
Weakness
1
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 13,854
Asset Value
₹ 3,064
3.5 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Granules India Ltd | 20 | 13,853 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,29,841 |
Divis Laboratories Ltd | 63 | 1,58,179 |
Cipla Ltd | 57 | 1,27,063 |
Mankind Pharma Ltd | 52 | 1,09,234 |
Dr Reddys Laboratories Ltd | 63 | 1,07,398 |
Historical Market Cap of Granules India Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Granules India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Granules India Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Granules India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Granules India Q2 PAT declines 5% YoY to Rs 97 cr
Profit before tax slipped 5.62% to Rs 128.38 crore in September 2024 quarter as against 13...
06 Nov 202414:39
Granules India receives USFDA approval for Bupropion Hydrochloride ER Tablets USP
Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approv...
18 Oct 202412:31
Granules India gets USFDA nod for antidepressant tablets
Bupropion hydrochloride extended-release tablets USP (SR) is bioequivalent and therapeutic...
18 Oct 202413:04
Granules India to announce Quarterly Result
Granules India will hold a meeting of the Board of Directors of the Company on 6 November ...
17 Oct 202417:07
Granules India Ltd spurts 0.27%, gains for fifth straight session
Granules India Ltd is up for a fifth straight session today. The stock is quoting at Rs 60...
14 Oct 202413:00
Granules India Ltd soars 1.15%
Granules India Ltd is up for a third straight session in a row. The stock is quoting at Rs...
10 Oct 202413:05
FAQs for EPS of Granules India Ltd
What is the EPS of Granules India Ltd stock?
How is Granules India Ltd EPS calculated?
How often does Granules India Ltd report its EPS?
What factors can influence Granules India Ltd EPS?
Can Granules India Ltd EPS growth indicate future performance?
Unlimited trading at just
Rs. 199*